SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059507
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:27
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20240331.htm   iXBRL 10-Q 1652041
2 EX-31.1 acet-ex31_1.htm EX-31.1 14774
3 EX-31.2 acet-ex31_2.htm EX-31.2 14904
4 EX-32.1 acet-ex32_1.htm EX-32.1 11589
  Complete submission text file 0000950170-24-059507.txt   7161109

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20240331.xsd EX-101.SCH 1389541
73 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240331_htm.xml XML 932442
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 24944217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)